F-group (family)
2003.1.5.44 MT-A70
Ligands and drugs
236
Member domains
145
with ligand contacts (≤ 4 Å)
61.4% of members
115
with DrugDomain annotations
48.7% of members
110
with a DrugBank compound
46.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.5.44 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01752 | SAH | S-adenosyl-L-homocysteine | 4 |
| DB00118 | SAM | Ademetionine | 3 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB00640 | ADN | Adenosine | 1 |
| DB01910 | SFG | Sinefungin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 14 |
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 12 |
| SAM | S-ADENOSYLMETHIONINE | 10 |
| CAmetal | CALCIUM ION | 5 |
| CL | CHLORIDE ION | 3 |
| BME | BETA-MERCAPTOETHANOL | 2 |
| SFG | SINEFUNGIN | 2 |
| UEE | (R)-4-((2-azaspiro[3.3]heptan-2-yl)methyl)-N-((1-(6-(benzylamino)pyrimidin-4-yl)-3-hydroxypiperidin-3-yl)methyl)benzamide | 2 |
| UNX | UNKNOWN ATOM OR ION | 2 |
| 0AE | (3~{R})-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]-3-[[[6-[[(3~{S})-3-propan-2-yl-2-azoniaspiro[3.3]heptan-2-yl]methyl]naphthalen-1-yl]amino]methyl]piperidin-3-ol | 1 |
| 0BA | 2-oxidanyl-N-[[(3R)-3-oxidanyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methyl]-4-[[(3S)-3-propan-2-yl-2-azaspiro[3.3]heptan-2-yl]methyl]benzamide | 1 |
| 0BH | N-[[(3R)-1-[6-(1-benzothiophen-4-ylmethylamino)pyrimidin-4-yl]-3-oxidanyl-piperidin-3-yl]methyl]-2-oxidanyl-4-[[(3S)-3-propan-2-yl-2-azaspiro[3.3]heptan-2-yl]methyl]benzamide | 1 |
| 6IK | 4-[[(3S)-3-cyclopropyl-2-azaspiro[3.3]heptan-2-yl]methyl]-N-[[(3S)-3-oxidanyl-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]piperidin-3-yl]methyl]benzamide | 1 |
| A1I4I | (3~{R})-~{N}-(cyclopropylmethyl)-1-[6-[3-[5-(5-cyclopropylpyridin-3-yl)-1,3,4-thiadiazol-2-yl]oxetan-3-yl]pyridin-3-yl]piperidin-3-amine | 1 |
| A1I4K | (3~{R})-~{N}-(cyclopropylmethyl)-1-[6-[3-[4-(5-cyclopropylpyridin-3-yl)-1,2,3-triazol-1-yl]oxetan-3-yl]pyridin-3-yl]piperidin-3-amine | 1 |
| A1III | 4-[(3~{R})-3-(cyclopropylmethylamino)piperidin-1-yl]-1-[(1~{R})-1-[4-[5-(dimethylamino)pyridin-3-yl]-1,2,3-triazol-1-yl]ethyl]pyridin-2-one | 1 |
| A1IIK | 4-[(3~{R})-3-(cyclobutylmethylamino)piperidin-1-yl]-1-[(1~{R})-1-[4-(5-methoxypyridin-3-yl)-1,2,3-triazol-1-yl]ethyl]pyridin-2-one | 1 |
| A1IIM | 4-[(3~{R})-3-(cyclopropylmethylamino)piperidin-1-yl]-1-[(1~{R})-1-[4-(6-pyrrolidin-1-ylpyrazin-2-yl)-1,2,3-triazol-1-yl]ethyl]pyridin-2-one | 1 |
| A1JDK | 1-(1~{H}-imidazol-2-yl)-2-phenyl-diazane | 1 |
| A1JI7 | 4-[[[4-[(4,4-dimethylpiperidin-1-yl)methyl]-2-oxidanyl-phenyl]amino]methyl]-1-(4-phenylmethoxypyridin-2-yl)piperidin-4-ol | 1 |